Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Euronext Paris  >  Sanofi    SAN   FR0000120578

SANOFI (SAN)

Delayed Quote. Delayed  - 02/21 05:35:07 pm
80.53 EUR   -0.02%
02/20 SANOFI : Disclosure of trading in own shares
02/17 SANOFI : JHL Biotech Form Strategic Partnership
02/16 SANOFI : brings Toujeo to local market
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

SANOFI : Former Sanofi employees convicted of bribery in Germany

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/03/2014 | 07:24pm CET

A German court convicted two former employees of Sanofi-Aventis on bribery charges 10 months ago and imposed a fine on the French drugmaker last year, prosecutors said on Monday following a newspaper report.

News of the 28 million euro ($39 million) fine coincides with heightened scrutiny of Big Pharma's sales practices after a bribery scandal in China hit business there last year.

Further investigations are ongoing, a spokesman for prosecutors in the northern German town of Verden said, confirming a report by German daily newspaper Frankfurter Allgemeine Zeitung, but they declined to say whether these were related to Sanofi or to its employees.

The spokesman said an investigation of the former Sanofi employees found that they had made illicit payments to a consultancy advising one of the drugmaker's clients between 2007 and 2010 to win more orders from the client, a pharmaceuticals dealer.

"Sanofi was unfairly given preference because of this," he said.

He declined to provide details on who the client was or which markets it operated in. He also did not name the former Sanofi employees or the consultant.

A court in the town of Winsen handed the two former employees of Sanofi suspended sentences for bribery in business transactions in May 2013, the spokesman said. They both worked with Sanofi's sales force and were not senior managers.

The Winsen court also ordered that punishment be meted out to the owner of the consultancy, but that judgment was not yet final due to a pending complaint against the ruling.

The bribery investigation has not come to light until now because the suspects were sentenced via a simplified legal process that under German law allows courts to try some crimes without a courtroom trial.

The court's ruling also resulted in a 28 million euro fine for Sanofi. A spokeswoman for Sanofi-Aventis Deutschland GmbH confirmed the company had to pay that sum in connection with the case against the two former employees.

"For Sanofi the matter is closed," the spokeswoman said, referring to the Winsen court's rulings. She added the company had cooperated with authorities during the investigation and had since further tightened its compliance system.

Sanofi acquired Aventis in 2004, creating Sanofi-Aventis. In 2011, the company simplified its name to Sanofi.

(Reporting by Maria Sheahan and Frank Siebelt; Additional reporting by Natalie Huet in Paris; Writing by Marilyn Gerlach; editing by Mike Collett-White)

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on SANOFI
02/20 SANOFI : Disclosure of trading in own shares
02/17 SANOFI : JHL Biotech Form Strategic Partnership
02/16 REGENERON PHARMACEUTICALS : Appeals Court Grants Stay of Permanent Injunction fo..
02/16 SANOFI : Researchers' Work from Sanofi Pasteur Focuses on Hepatitis (Immunogenic..
02/16 SANOFI : Researchers from Sanofi Report Recent Findings in Osteoarthritis (I kap..
02/16 SANOFI : brings Toujeo to local market
02/16 How Sanofi lost out to J&J in $30 billion battle for Actelion
02/16 IPSEN : Acquires Five Sanofi Consumer Healthcare Products
02/15 SANOFI -FEBRUARY 4&15 : World Cancer Days
02/15 IPSEN : to Acquire a Portfolio of Select Consumer Healthcare Products from Sanof..
More news
Sector news : Pharmaceuticals - NEC
02:05aDJBRISTOL MYERS SQUIBB : Carl Icahn Takes Stake in Bristol-Myers Squibb -- 2nd Upd..
02/21 Icahn buys Bristol-Myers shares, adding to activist pressure
02/21 Collapse of Kraft-Unilever tie-up extends run of failed mega-deals
02/21DJBRISTOL MYERS SQUIBB : Carl Icahn Takes Stake in Bristol-Myers Squibb -- Update
02/21DJBRISTOL MYERS SQUIBB : Carl Icahn Takes Stake in Bristol-Myers Squibb -- Sources
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
02/21 PROTALIX BIOTHERAPEUTICS : New Institutional Ownership Swells Ahead Of Major Cat..
02/21 A Time To Buy Novo Nordisk
02/21 HEPATITIS B MARKET : Emerging Players Could Make The Difference
02/17 MannKind - Afrezza Sales Slip As New Sales Force Starts
02/17 What Makes Amgen A Compelling Buy In 2017?
Advertisement
Financials (€)
Sales 2017 36 446 M
EBIT 2017 9 200 M
Net income 2017 5 873 M
Debt 2017 4 565 M
Yield 2017 3,79%
P/E ratio 2017 14,84
P/E ratio 2018 16,89
EV / Sales 2017 2,98x
EV / Sales 2018 2,86x
Capitalization 104 072 M
More Financials
Chart SANOFI
Duration : Period :
Sanofi Technical Analysis Chart | SAN | FR0000120578 | 4-Traders
Full-screen chart
Technical analysis trends SANOFI
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Average target price 82,2 €
Spread / Average Target 2,0%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Olivier Brandicourt Chief Executive Officer & Director
Serge Weinberg Chairman
Jérôme Contamine Chief Financial Officer & EVP-Finance
Elias E. Zerhouni President-Global Research & Development
Yong-Jun Liu Head-Global Research & Development
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
SANOFI4.75%110 189
JOHNSON & JOHNSON3.17%323 362
ROCHE HOLDING LTD.4.69%209 882
PFIZER INC.3.51%204 018
NOVARTIS AG3.91%200 997
MERCK & CO., INC.11.08%180 289
More Results